We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12B
AUM Growth
-$882M
Cap. Flow
-$307M
Cap. Flow %
-2.56%
Top 10 Hldgs %
23.8%
Holding
2,895
New
41
Increased
683
Reduced
1,007
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 13.65%
3 Financials 12.21%
4 Consumer Discretionary 10.98%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVA icon
1826
Innoviva
INVA
$1.5B
$384K ﹤0.01%
33,073
OLO
1827
DELISTED
Olo Inc
OLO
$383K ﹤0.01%
48,520
KAMN
1828
DELISTED
Kaman Corp
KAMN
$383K ﹤0.01%
13,707
DMC
1829
Del Monte Corp
DMC
$1.44B
$383K ﹤0.01%
16,470
+1,905
+13% +$53.1K
AER icon
1830
AerCap
AER
$23.5B
$381K ﹤0.01%
9,000
HWKN icon
1831
Hawkins
HWKN
$2.67B
$381K ﹤0.01%
9,766
ALKT icon
1832
Alkami Technology
ALKT
$2.22B
$381K ﹤0.01%
25,300
+7,525
+42% +$110K
GDEN
1833
DELISTED
Golden Entertainment
GDEN
$380K ﹤0.01%
10,896
+860
+9% +$34.4K
MATW icon
1834
Matthews International
MATW
$722M
$379K ﹤0.01%
16,919
TA
1835
DELISTED
TravelCenters of America LLC
TA
$379K ﹤0.01%
7,030
-605
-8% -$30.1K
DLX icon
1836
Deluxe
DLX
$1.11B
$379K ﹤0.01%
22,763
LICY
1837
DELISTED
Li-Cycle Holdings Corp.
LICY
$378K ﹤0.01%
8,888
PRDO icon
1838
Perdoceo Education
PRDO
$1.99B
$378K ﹤0.01%
36,674
+7,021
+24% +$83.9K
FMTX
1839
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$377K ﹤0.01%
18,921
+4,638
+32% +$61.2K
PUBM icon
1840
PubMatic
PUBM
$787M
$377K ﹤0.01%
22,685
CINC
1841
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$376K ﹤0.01%
11,457
+3,367
+42% +$95.2K
MLAB icon
1842
Mesa Laboratories
MLAB
$633M
$376K ﹤0.01%
2,668
PRG icon
1843
PROG Holdings
PRG
$1.7B
$375K ﹤0.01%
25,019
-5,253
-17% -$98.6K
LPSN icon
1844
LivePerson
LPSN
$35.9M
$375K ﹤0.01%
2,652
+299
+13% +$57.3K
DM
1845
DELISTED
Desktop Metal, Inc.
DM
$374K ﹤0.01%
14,446
HIMS icon
1846
Hims & Hers Health
HIMS
$6.71B
$374K ﹤0.01%
67,047
AVXL icon
1847
Anavex Life Sciences
AVXL
$303M
$374K ﹤0.01%
36,249
+2,553
+8% +$26.9K
CHRS icon
1848
Coherus Oncology
CHRS
$176M
$374K ﹤0.01%
38,891
+4,003
+11% +$40.5K
CUTR
1849
DELISTED
Cutera, Inc.
CUTR
$374K ﹤0.01%
8,191
-708
-8% -$32.3K
REPL icon
1850
Replimune Group
REPL
$1.42B
$373K ﹤0.01%
21,626
+6,417
+42% +$122K

Similar funds

MetLife Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, MetLife Investment Management held 2,895 positions worth $12B, down 6.8% from $12.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. MetLife Investment Management opened 41 new positions and exited 96, leaving the 2,895-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q3 2022 buy was Aspen Technology Inc: 19,662 shares worth $4.68M.
  • MetLife Investment Management added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $24.5M increase.
  • MetLife Investment Management's biggest Q3 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $138M.
  • MetLife Investment Management fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.77M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12B portfolio in Q3 2022.
  • MetLife Investment Management opened 41 new positions and closed 96 in Q3 2022.
  • MetLife Investment Management's portfolio value fell 6.8% quarter-over-quarter to $12B.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.